pharmaphorum

FEBRUARY 15, 2022

The findings point to a “threat to environmental and global health,” say the scientists, who found that paracetamol, antibiotics epilepsy drug carbamazepine, metformin for diabetes and other compounds like caffeine and nicotine were found in samples from around the world – including in Antarctica.

Compounding 105

Compounding Pharmaceutical Manufacturing Diabetes 105

Pharmaceutical Technology

APRIL 18, 2023

Lilly chair and CEO Dave Ricks said: “Through these new facilities, Hoosiers [workers from the state of Indiana] will make life-changing medicines that patients around the world need to address serious health challenges, including diabetes and cancer. “We’re Last year, the company committed to providing $42.5m

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Diabetes 52

Pharmaceutical Technology

JUNE 23, 2025

SDoH can influence diabetes risk and management, and access to healthcare can also affect disease management and progression. One study dove into whether annual income influenced choice in GLP-1 RA therapy for patients with Type 2 Diabetes. medication accessibility), especially in cases where there are multiple in-class agents.”

Insurance Coverage and Processing 82

Insurance Coverage and Processing Diabetes Pharmaceutical Manufacturing Communication 82

Pharmaceutical Technology

JUNE 23, 2025

Eylea is approved in four indications in Europe: the treatment of ‘wet’ age-related macular degeneration (AMD), visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV).

Biosimilars 52

Biosimilars Pharmaceutical Manufacturing Communication Hospitals 52

European Pharmaceutical Review

DECEMBER 18, 2023

Additionally, in October, EPR shared Phase III trial data for the type 1 diabetes treatment TZIELD (Teplizumab), which suggested that the medicine could slow disease progression. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Hospitals Diabetes 98

pharmaphorum

APRIL 4, 2022

The Fund – set up as a public-private partnership by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) – started life with $1 billion earmarked to support companies trying to develop antibiotics that can be used to replace those that have started to lose their effectiveness.

Pharmaceutical Manufacturing 64

Pharmaceutical Manufacturing Diabetes Hospitals 64

pharmaphorum

NOVEMBER 25, 2022

A respiratory platform similar to the diabetes one, the Digital Health Solution is yet another future-looking inclusion in the Chiesi plan. Having built a considerable reputation via its immunotherapies and respiratory products, Chiesi’s first rare disease drug is zampilimab, a novel monoclonal antibody for fibrotic lung diseases.

Drug Development 98

Drug Development Pharmaceutical Manufacturing Diabetes 98

PharmaShots

FEBRUARY 27, 2023

facility for manufacturing biologics in his presentation. —a combination of AI, IoT, and Digital Twins—for pharmaceutical manufacturers. Dr. Samir discussed Agilent's new Agilent University idea as well as how the company is creating analytical solutions to enable the smart manufacture of biologics.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Pharmacy Times

JUNE 4, 2025

The Advanced Technologies Lab will help industry and regulators accelerate the adoption of new technologies that help to mitigate supply chain risks and, where appropriate, establish guidance that supports regulatory predictability, process efficiencies, and faster time to market, all of which can strengthen domestic manufacturing capabilities.

Pharmaceutical Manufacturing 26

Pharmaceutical Manufacturing Pharmacy Technician Compounding Pharmacies Compounding 26

Ramblings of a pharmacist

DECEMBER 27, 2024

We can also see from this excerpt that at the scale of large PBMs, formulary strategies are also a piece of negotiating leverage to obtain rebates and fees from pharmaceutical manufacturers. However, once negotiations are completed and rebate contracted executed, rebates can be cut off punitively by pharmaceutical manufacturers.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Specialty Pharmacies Documentation Hospitals 98

pharmaphorum

JULY 28, 2022

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. A break in the supply chain could have enormous implications for millions of people suffering from these conditions.

Diabetes 111

Diabetes Dosage Pharmaceutical Manufacturing Documentation 111

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 104

Pharmacy Times

JUNE 23, 2025

For submission consideration, manufacturers can petition the FDA for ANDA status if the requested change does not require safety or effectiveness studies. It is basically an essential copy, and the pharmaceutical manufacturer has to show bioequivalence to the reference product,” Soefje said. “If

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmaceutical Technology

MARCH 22, 2023

Biologics and antibiotics could be worst hit due to their energy-intensive manufacturing processes, along with the supply of glass vials and syringes disrupting the supply chain. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmacy Times

JUNE 8, 2025

This involves close coordination with specialty pharmacies, infusion services, retail pharmacies, pharmaceutical manufacturers, medication access programs, and industry representatives. In many cases, the pharmacist resolves the issue independently, escalating to the provider only when necessary.

Pharmacy Technician 29

Pharmacy Technician Specialty Pharmacies Communication Immunization 29

Pharmaceutical Technology

MAY 16, 2023

Juno Pharmaceuticals Canada has purchased Omega Laboratories, a specialist injectable pharmaceutical manufacturer in Canada, for an undisclosed sum. The merged entity represents one of the biggest specialist generic injectable operations in Canada with local manufacturing facilities.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Diabetes Vaccines 52

Quality Matters

OCTOBER 13, 2021

Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient. By enabling a multi-manufacturer environment, USP standards have helped increase the availability of medicines to treat cardiovascular disease, cancer, diabetes, mental health and many other conditions.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Pharmacy Times

JUNE 12, 2025

5 The Most Significant Driver of Health Care Spend Isn’t Drugs—It Isn’t Even Close Pharmaceutical manufacturers are a frequent punching bag for politicians, mostly because they are easy targets, and they tend to have more visible out-of-pocket exposure.

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

Pharmacy Times

JUNE 16, 2025

3,4 How this pricing model will be implemented and whether pharmaceutical manufacturers will be able to meet the expectations of the 2025 executive order, if upheld, is uncertain. The order states that if manufacturers are unable to meet the 30-day deadline, the secretary of the Department of Health and Human Services, Robert F.

Pharmacy Technician 26

Pharmacy Technician Drug Pricing Insurance Coverage and Processing Compounding Pharmacies 26